Octreotide acetate and Z-e syndrome - a phase IV clinical study of FDA data
Z-e syndrome is reported only by a few people who take Octreotide Acetate.
The phase IV clinical study analyzes which people take Octreotide acetate and have Z-e syndrome. It is created by eHealthMe based on reports of 1,884 people who have side effects while taking Octreotide acetate from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,884 people reported to have side effects when taking Octreotide acetate.
Among them, 1 person (0.05%) has Z-e syndrome.
What is Octreotide acetate?
Octreotide acetate has active ingredients of octreotide acetate. eHealthMe is studying from 1,903 Octreotide acetate users for its effectiveness, alternative drugs and more.
What is Z-e syndrome?
Z-e syndrome (increased production of the hormone gastrin from a small tumour of pancreas) is found to be associated with 153 drugs and 170 conditions by eHealthMe.
Number of Octreotide acetate and Z-e syndrome reports submitted per year:
Gender of people who have Z-e syndrome when taking Octreotide acetate *:
- female: 0.0 %
- male: 100 %
Age of people who have Z-e syndrome when taking Octreotide acetate *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Octreotide acetate *:
- Vitamin D: 1 person, 100.00%
- Protonix: 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Octreotide acetate and have Z-e syndrome?Check whether Z-e syndrome is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
- Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .
How severe was Z-e syndrome and when was it recovered:
Expand to all the drugs that have ingredients of octreotide acetate:
Alternative drugs to, pros and cons of Octreotide acetate:
- Octreotide acetate (1,903 reports)
Common Octreotide acetate side effects:
- Diarrhea: 295 reports
- Fatigue (feeling of tiredness): 180 reports
- Abdominal pain: 152 reports
- High blood pressure: 140 reports
- Nausea and vomiting: 136 reports
- Death: 122 reports
- Hypotension (abnormally low blood pressure): 116 reports
Browse all side effects of Octreotide acetate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Z-e syndrome treatments and more:
- Z-e syndrome (1,123 reports)
COVID vaccines that are related to Z-e syndrome:
- Z-e syndrome in Moderna COVID Vaccine
- Z-e syndrome in Pfizer BioNTech Covid Vaccine
- Z-e syndrome in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Z-e syndrome:
- Z-e syndrome (153 drugs)
All the conditions that are associated with Z-e syndrome:
- Z-e syndrome (170 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on octreotide acetate (the active ingredients of Octreotide acetate) and Octreotide acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Decadron and Lactose Intolerance - 3 seconds ago
- Welchol and Adenocarcinoma Pancreas - 4 seconds ago
- Lanirapid and Sensation Of Heaviness - 4 seconds ago
- Daypro and Extrasystoles - 12 seconds ago
- Demerol and Drug Detoxification - 14 seconds ago
- Darzalex and Performance Status Decreased - 14 seconds ago
- Decadron and Hypertensive Heart Disease - 15 seconds ago
- Daypro and Endometriosis - 17 seconds ago
- Decadron and Lower Gastrointestinal Haemorrhage - 17 seconds ago
- Synagis and Meningitis Viral - 20 seconds ago